全部 |
  • 全部
  • 题名
  • 关键词
  • NSTL主题词
  • 摘要
  • 论文-出处
  • 论文-作者
  • 论文-机构
  • 论文-DOI
  • 期刊-出版者
  • 期刊-出版地
  • 期刊-主编
  • ISSN
  • EISSN
  • ISBN
  • EISBN
检索 搜索期刊 二次检索 AI检索
外文文献 中文文献
筛选条件:

1. A nationwide epidemiological study of myasthenia gravis in Turkey NSTL国家科技图书文献中心

Inan, Berin |  Ozturk, Bilgin... -  《Journal of neurology》 - 2025,272(1) - Article: 5~Article: 5 - 共7页

摘要: rates of myasthenia gravis (MG) have been reported | BackgroundVariable incidence and prevalence |  over time from different geographical regions. We |  aimed to determine incidence and prevalence of MG in |  Turkey and contribute to the development of proper
关键词: Myasthenia gravis |  Incidence |  Prevalence |  Epidemiology

2. Diabetes mellitus in patients with myasthenia gravis: a systematic review and meta-analysis NSTL国家科技图书文献中心

Shao, Tianrui |  Lu, Jing... -  《Endocrine.》 - 2025,88(1) - 24~35 - 共12页

摘要: expectancy in patients with myasthenia gravis, the number |  with myasthenia gravis. However, there is not enough |  gravis and whether the myasthenia gravis is associated |  23,516 myasthenia gravis patients, the prevalence of |  that myasthenia gravis was significantly associated
关键词: Diabetes mellitus |  Myasthenia gravis |  Prevalence rate |  Systematic review |  Meta-analysis

3. Individualized Dosing of Efgartigimod in Patients With Generalized Myasthenia Gravis: Clinical Experience at a Single Center NSTL国家科技图书文献中心

Silvestri, Nicholas ... -  《Muscle and Nerve》 - 2025,71(3) - 422~428 - 共7页 - 被引量:1

摘要: patients with generalized myasthenia gravis (gMG |  measured by the Myasthenia Gravis Activities of Daily | Introduction/AimsNeonatal Fc receptor (FcRn | ) inhibitors represent a promising treatment option for | ); however, data on clinical use are limited. The aim of
关键词: corticosteroids |  efgartigimod |  generalized myasthenia gravis |  Myasthenia Gravis Activities of Daily Living |  retrospective study

4. Factors affecting the diagnostic delay of myasthenia gravis NSTL国家科技图书文献中心

Marlet, I. R. |  Andersen, R. K.... -  《Journal of neurology》 - 2025,272(1) - Article: 29~Article: 29 - 共10页

摘要: myasthenia gravis (MG) is important to improve the chance | BackgroundEarly detection and diagnosis of |  of remission and overall prognosis. This study aims |  to investigate the factors affecting the diagnostic |  delay of MG thereby highlighting the challenges in the
关键词: Myasthenia gravis |  Neuromuscular junction |  Diagnosis |  Diagnostic process |  Time to diagnosis |  Delay

5. Predictors of achieving minimal manifestations or better status in ocular myasthenia gravis with immunotherapy NSTL国家科技图书文献中心

Komatsu, Teppei |  Motegi, Haruhiko... -  《Journal of neurology》 - 2025,272(3) - Article 243~Article 243 - 共4页

摘要:Background Ocular myasthenia gravis (MG | ), while less severe than generalized MG, significantly |  impairs quality of life due to its impact on vision and |  daily activities. Immunotherapy is a key treatment | , yet the optimal timing for initiation remains
关键词: Ocular myasthenia gravis |  Immunotherapy |  Prognosis

6. Prevalence and course of muscle-specific receptor tyrosine kinase (MuSK) antibodies in myasthenia gravis - A retrospective study NSTL国家科技图书文献中心

Jan-Hendrik Stahl |  Max Konle... -  《Journal of the Neurological Sciences》 - 2025,472 - 123449~123449 - 共7页

摘要:Myasthenia gravis is a neuromuscular disease |  autoantibodies. For MuSK-positive Myasthenia gravis cases, we |  biomarkers of Myasthenia gravis severity, and they shed |  typically associated with acetylcholine receptor (AChR | ) autoan-tibodies. However, in AChR-negative cases
关键词: Biomarker, ELISA, RIA, Autoimmune, Myasthenia gravis

7. Myasthenia gravis in 2025: five new things and four hopes for the future NSTL国家科技图书文献中心

Binks, S. N. M. |  Morse, I. M.... -  《Journal of neurology》 - 2025,272(3) - Article 226~Article 226 - 共23页

摘要: developments in the effective treatment of myasthenia gravis |  thymectomy in myasthenia gravis that demonstrated efficacy | The last 10 years has brought transformative |  (MG). Beginning with the randomized trial of |  of thymectomy in nonthymomatous MG, several new
关键词: Clinical guidelines |  Myasthenia gravis |  Neuromuscular junction |  Thymectomy |  Older adults |  Rituximab

8. Eculizumab in refractory myasthenia gravis: a real-world single-center experience NSTL国家科技图书文献中心

Ricciardi, Dario |  Erra, Carmen... -  《Neurological sciences》 - 2025,46(2) - 951~959 - 共9页 - 被引量:1

摘要: effective in most Myasthenia gravis patients, but 10-15 |  of refractory myasthenia gravis patients with | IntroductionImmunosuppressive treatment is | % of patients areconsidered refractory due to |  inadequate response or intolerance to therapy. Eculizumab
关键词: Complement inhibitor |  Myasthenia gravis |  Eculizumab |  Real world evidence

9. Pitfalls in the Evaluation of Respiratory Failure in Myasthenia Gravis Patients: A Case Series NSTL国家科技图书文献中心

Uysal, Sanem Pinar |  Li, Yuebing -  《The Neurohospitalist》 - 2025,15(2) - 151~154 - 共4页

摘要: myasthenia gravis (MG) patients. Methods: We describe 3 | Objectives: To highlight the importance of |  recognizing different presentations of respiratory failure |  due to myasthenic and non-myasthenic etiologies in |  patients with different presentations of respiratory
关键词: myasthenia gravis |  myasthenic crisis |  myasthenia exacerbation |  respiratory distress

10. The JAK1/3 Inhibitor Tofacitinib Regulates Th Cell Profiles and Humoral Immune Responses in Myasthenia Gravis NSTL国家科技图书文献中心

Bi, Zhuajin |  Zhang, Qing... -  《Muscle and Nerve》 - 2025,71(3) - 474~486 - 共13页 - 被引量:1

摘要: arthritis. However, its role in myasthenia gravis (MG |  autoimmune myasthenia gravis (EAMG) and peripheral blood | Introduction/AimsTofacitinib, a first | -generation Janus kinase (JAK) 1/3 inhibitor, is commonly |  used for treating ulcerative colitis and rheumatoid
关键词: B cells |  JAK/STAT pathway |  myasthenia gravis |  T helper cells |  tofacitinib
检索条件Myasthenia gravis
  • 检索词扩展

NSTL主题词

  • NSTL学科导航